Gross Profit Summary of ProText Mobility, Inc.

ProText Mobility, Inc.'s latest annual gross profit in 2023 was - USD , down 0.0% from previous year.
ProText Mobility, Inc.'s latest quarterly gross profit in 2024 Q2 was - USD , down 0.0% from previous quarter.
ProText Mobility, Inc. reported a annual gross profit of - USD in annual gross profit 2022, down 0.0% from previous year.
ProText Mobility, Inc. reported a annual gross profit of - USD in annual gross profit 2021, down 0.0% from previous year.
ProText Mobility, Inc. reported a quarterly gross profit of - USD for 2024 Q1, down 0.0% from previous quarter.
ProText Mobility, Inc. reported a quarterly gross profit of - USD for 2023 Q3, down 0.0% from previous quarter.

Annual Gross Profit Chart of ProText Mobility, Inc. (2023 - 2002)

Historical Annual Gross Profit of ProText Mobility, Inc. (2023 - 2002)

Year	Gross Profit	Gross Profit Growth
2023	- USD	0.0%
2022	- USD	0.0%
2021	- USD	0.0%
2020	- USD	0.0%
2019	- USD	0.0%
2018	- USD	0.0%
2017	- USD	0.0%
2016	- USD	0.0%
2013	642.00 USD	100.37%
2012	-171.25 Thousand USD	-47.58%
2011	-116.04 Thousand USD	49.69%
2010	-230.66 Thousand USD	-348.84%
2009	-51.39 Thousand USD	65.81%
2008	-150.3 Thousand USD	-490.11%
2007	38.52 Thousand USD	-80.04%
2006	193.01 Thousand USD	169.55%
2005	71.6 Thousand USD	211.81%
2004	-64.03 Thousand USD	-222.8%
2003	-19.83 Thousand USD	65.65%
2002	-57.75 Thousand USD	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q2	- USD	0.0%
2024 Q1	- USD	0.0%
2023 Q3	- USD	0.0%
2023 Q4	- USD	0.0%
2023 FY	- USD	0.0%
2023 Q1	- USD	0.0%
2023 Q2	- USD	0.0%
2022 Q2	- USD	0.0%
2022 FY	- USD	0.0%
2022 Q1	- USD	0.0%
2022 Q3	- USD	0.0%
2022 Q4	- USD	0.0%
2021 Q3	- USD	0.0%
2021 Q1	- USD	0.0%
2021 FY	- USD	0.0%
2021 Q2	- USD	0.0%
2021 Q4	- USD	0.0%
2020 FY	- USD	0.0%
2019 FY	- USD	0.0%
2018 FY	- USD	0.0%
2017 FY	- USD	0.0%
2016 FY	- USD	0.0%
2014 Q1	- USD	0.0%
2014 Q3	647.00 USD	0.0%
2014 Q2	- USD	0.0%
2013 Q1	265.00 USD	100.27%
2013 FY	642.00 USD	100.37%
2013 Q4	- USD	0.0%
2013 Q2	377.00 USD	42.26%
2013 Q3	- USD	-100.0%
2012 Q1	-21.9 Thousand USD	66.49%
2012 Q3	-25.2 Thousand USD	-2.46%
2012 FY	-171.25 Thousand USD	-47.58%
2012 Q4	-99.55 Thousand USD	-294.99%
2012 Q2	-24.59 Thousand USD	-12.32%
2011 Q1	-15.51 Thousand USD	89.49%
2011 Q2	-15.9 Thousand USD	-2.54%
2011 Q3	-19.27 Thousand USD	-21.17%
2011 Q4	-65.35 Thousand USD	-239.15%
2011 FY	-116.04 Thousand USD	49.69%
2010 Q2	-26.17 Thousand USD	-4.23%
2010 FY	-230.66 Thousand USD	-348.84%
2010 Q4	-147.54 Thousand USD	-360.58%
2010 Q3	-32.03 Thousand USD	-22.41%
2010 Q1	-25.1 Thousand USD	67.13%
2009 Q4	-76.38 Thousand USD	-1044.07%
2009 FY	-51.39 Thousand USD	65.81%
2009 Q1	8853.00 USD	-84.21%
2009 Q2	8050.00 USD	-9.07%
2009 Q3	8091.00 USD	0.51%
2008 FY	-150.3 Thousand USD	-490.11%
2008 Q4	56.07 Thousand USD	134.43%
2008 Q3	-162.87 Thousand USD	-4772.15%
2008 Q2	3486.00 USD	-93.3%
2008 Q1	52 Thousand USD	138.42%
2007 Q4	-135.37 Thousand USD	-220.66%
2007 FY	38.52 Thousand USD	-80.04%
2007 Q2	-122.44 Thousand USD	-166.49%
2007 Q1	184.14 Thousand USD	105.86%
2007 Q3	112.19 Thousand USD	191.63%
2006 Q3	85.38 Thousand USD	592.83%
2006 FY	193.01 Thousand USD	169.55%
2006 Q2	12.32 Thousand USD	110.67%
2006 Q1	5850.00 USD	-69.67%
2006 Q4	89.45 Thousand USD	4.76%
2005 Q2	13.27 Thousand USD	202.1%
2005 FY	71.6 Thousand USD	211.81%
2005 Q1	-13 Thousand USD	-15.28%
2005 Q3	38.75 Thousand USD	191.9%
2005 Q4	19.28 Thousand USD	-50.24%
2004 FY	-64.03 Thousand USD	-222.8%
2004 Q2	-22.02 Thousand USD	-30.5%
2004 Q3	-13.85 Thousand USD	37.13%
2004 Q1	-16.88 Thousand USD	-284.42%
2004 Q4	-11.28 Thousand USD	18.56%
2003 Q1	-4900.00 USD	0.0%
2003 FY	-19.83 Thousand USD	65.65%
2003 Q4	-4391.00 USD	34.15%
2003 Q3	-6668.00 USD	-71.9%
2003 Q2	-3879.00 USD	20.84%
2002 FY	-57.75 Thousand USD	0.0%

Peer Gross Profit Comparison of ProText Mobility, Inc.

Name	Gross Profit	Gross Profit Difference
Burzynski Research Institute, Inc.	- USD	NaN%
Arch Therapeutics, Inc.	-2439.00 USD	100.0%
Evofem Biosciences, Inc.	11.7 Million USD	100.0%
Nascent Biotech, Inc.	-319.5 Thousand USD	100.0%
Rebus Holdings, Inc.	- USD	NaN%
Santhera Pharmaceuticals Holding AG	119.1 Million USD	100.0%
Qrons Inc.	- USD	NaN%
Adynxx, Inc.	- USD	NaN%
Neon Bloom, Inc.	- USD	NaN%
Northwest Biotherapeutics, Inc.	-25.79 Million USD	100.0%
ProtoKinetix, Incorporated	-48.25 Thousand USD	100.0%
Skye Bioscience, Inc.	-124.25 Thousand USD	100.0%
Eiger BioPharmaceuticals, Inc.	14.99 Million USD	100.0%
Nanobac Pharmaceuticals, Incorporated	3102.00 USD	100.0%
Institute of Biomedical Research Corp.	- USD	NaN%
SQZ Biotechnologies Company	9.79 Million USD	100.0%
Intellipharmaceutics International Inc.	65.72 Thousand USD	100.0%
Propanc Biopharma, Inc.	-34.15 Thousand USD	100.0%
Mesoblast Limited	-35.16 Million USD	100.0%
Marizyme, Inc.	457.7 Thousand USD	100.0%
Genus plc	178.7 Million USD	100.0%
VioQuest Pharmaceuticals, Inc.	- USD	NaN%
Pharming Group N.V.	220.1 Million USD	100.0%
Therapeutic Solutions International, Inc.	62.22 Thousand USD	100.0%
CNBX Pharmaceuticals Inc.	410.16 Thousand USD	100.0%
Nymox Pharmaceutical Corporation	-11 Thousand USD	100.0%
ContraFect Corporation	-154 Thousand USD	100.0%
PsyBio Therapeutics Corp.	-50 Thousand USD	100.0%
Sienna Biopharmaceuticals, Inc.	- USD	NaN%
RegeneRx Biopharmaceuticals, Inc.	76.76 Thousand USD	100.0%
IMV Inc.	-962.29 Thousand USD	100.0%
AXIM Biotechnologies, Inc.	-387.5 Thousand USD	100.0%
MultiCell Technologies, Inc.	49.32 USD	100.0%
ONE Bio Corp.	20.12 Million USD	100.0%
Accustem Sciences Inc.	- USD	NaN%
RVL Pharmaceuticals plc	40.26 Million USD	100.0%
Arno Therapeutics, Inc.	- USD	NaN%
EV Biologics, Inc.	48.9 Thousand USD	100.0%
Q BioMed Inc.	-8988.00 USD	100.0%
Emmaus Life Sciences, Inc.	28.25 Million USD	100.0%
Mosaic ImmunoEngineering Inc.	- USD	NaN%
Biomind Labs Inc.	-15.42 Thousand USD	100.0%
American Oriental Bioengineering, Inc.	44.35 Million USD	100.0%
Provectus Biopharmaceuticals, Inc.	-1.14 Million USD	100.0%
TetraLogic Pharmaceuticals Corporation	- USD	NaN%
Oncotelic Therapeutics, Inc.	70 Thousand USD	100.0%
GlobeStar Therapeutics Corporation	- USD	NaN%
THC Farmaceuticals, Inc.	-4952.00 USD	100.0%
Acro Biomedical Co., Ltd.	140.5 Thousand USD	100.0%
Curative Biotechnology, Inc.	-97.51 Thousand USD	100.0%
GB Sciences, Inc.	-624.00 USD	100.0%
Alpha Cognition Inc.	-86.02 Thousand USD	100.0%
HST Global, Inc.	- USD	NaN%
CSL Limited	7.56 Billion USD	100.0%
Wesana Health Holdings Inc.	- USD	NaN%
Halberd Corporation	-208.00 USD	100.0%
Enzolytics Inc.	30.7 Thousand USD	100.0%
Agentix Corp.	- USD	NaN%
Resverlogix Corp.	- USD	NaN%
Nuo Therapeutics, Inc.	482.43 Thousand USD	100.0%
MetaStat, Inc.	- USD	NaN%
argenx SE	1.1 Billion USD	100.0%
Enzon Pharmaceuticals, Inc.	- USD	NaN%
Endonovo Therapeutics, Inc.	-514.51 Thousand USD	100.0%
RespireRx Pharmaceuticals Inc.	- USD	NaN%
GeneThera, Inc.	- USD	NaN%
Inhibitor Therapeutics, Inc.	- USD	NaN%
AVAX Technologies, Inc.	617.38 Thousand USD	100.0%
Zenith Capital Corp.	- USD	NaN%
Genscript Biotech Corporation	409.55 Million USD	100.0%
Ember Therapeutics, Inc.	- USD	NaN%
Anthera Pharmaceuticals, Inc.	- USD	NaN%
Sigyn Therapeutics, Inc.	-8856.00 USD	100.0%
WPD Pharmaceuticals Inc.	- USD	NaN%
Cotinga Pharmaceuticals Inc.	-83.84 Thousand USD	100.0%
Kadimastem Ltd	-630.13 Thousand USD	100.0%
Helix BioMedix, Inc.	987.98 Thousand USD	100.0%
VitaSpring Biomedical Co. Ltd.	- USD	NaN%
Capstone Therapeutics Corp.	9.61 Million USD	100.0%
BioStem Technologies, Inc.	15.42 Million USD	100.0%
Oncology Pharma Inc.	- USD	NaN%
Reve Technologies, Inc.	- USD	NaN%
LadRx Corporation	-11.83 Thousand USD	100.0%
Cell Source, Inc.	- USD	NaN%
Regen BioPharma, Inc.	176.56 Thousand USD	100.0%
Regen BioPharma, Inc.	176.56 Thousand USD	100.0%
NovAccess Global Inc.	- USD	NaN%
Affymax, Inc.	1.35 Million USD	100.0%
Itoco Inc.	- USD	NaN%
Rasna Therapeutics, Inc.	- USD	NaN%
Pathfinder Cell Therapy, Inc.	- USD	NaN%
Mobile Lads Corp.	- USD	NaN%
CytoDyn Inc.	-29 Thousand USD	100.0%
Claritas Pharmaceuticals, Inc.	- USD	NaN%
NDT Pharmaceuticals Inc.	- USD	NaN%
NanoSphere Health Sciences Inc.	- USD	NaN%
Alseres Pharmaceuticals, Inc.	450.04 Thousand USD	100.0%
SYBLEU INC	11.69 Thousand USD	100.0%
Advanced Proteome Therapeutics Corporation	- USD	NaN%
ImmunoCellular Therapeutics, Ltd.	- USD	NaN%
International Stem Cell Corporation	4.6 Million USD	100.0%
Bioxytran, Inc.	-8285.00 USD	100.0%
GlobeImmune, Inc.	- USD	NaN%
Predictive Technology Group, Inc.	- USD	NaN%
Cardax, Inc.	- USD	NaN%
VG Life Sciences Inc.	- USD	NaN%
Kaleido Biosciences, Inc.	- USD	NaN%
Advaxis, Inc.	- USD	NaN%
Adhera Therapeutics, Inc.	- USD	NaN%
RenovaCare, Inc.	- USD	NaN%
Regnum Corp.	- USD	NaN%
Innovation Pharmaceuticals Inc.	-373 Thousand USD	100.0%
Neutra Corp.	14.33 Thousand USD	100.0%
Windtree Therapeutics, Inc.	-82 Thousand USD	100.0%
PureTech Health plc	-1.6 Million USD	100.0%
Coeptis Therapeutics, Inc.	-1 Million USD	100.0%
IXICO plc	3.27 Million USD	100.0%
IntelGenx Technologies Corp.	-694 Thousand USD	100.0%
Gelesis Holdings, Inc.	-1.79 Million USD	100.0%
CSL Limited	7.7 Billion USD	100.0%
Cellectis S.A.	18 Thousand USD	100.0%

Global Stocks Search

ProText Mobility, Inc. (TXTM)

Gross Profit Summary of ProText Mobility, Inc.

Annual Gross Profit Chart of ProText Mobility, Inc. (2023 - 2002)

Historical Annual Gross Profit of ProText Mobility, Inc. (2023 - 2002)

Peer Gross Profit Comparison of ProText Mobility, Inc.